Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

Anastasios Roumeliotis,Bimmer E. Claessen,George Dangas,R Torguson,Samantha Sartori,Adam M. Reisman,Davide Cao,Rishi Chandiramani,Johny Nicolas,Ridhima Goel,Mauro Chiarito,Madhav Sharma,Dhrubajyoti Bandyopadhyay,Usman Baber,Joseph Sweeny,Nitin Barman,Samin K. Sharma,Annapoorna Kini,Roxana Mehran

Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

2020

Anastasios Roumeliotis
Bimmer E. Claessen
George Dangas
R Torguson
Samantha Sartori
Adam M. Reisman
Davide Cao
Rishi Chandiramani
Johny Nicolas
Ridhima Goel
Mauro Chiarito
Madhav Sharma
Dhrubajyoti Bandyopadhyay
Usman Baber
Joseph Sweeny
Nitin Barman
Samin K. Sharma
Annapoorna Kini
Roxana Mehran

Abstract Low levels of high-density lipoprotein (HDL) have been associated with adverse cardiovascular events in epidemiologic studies. Evidence regarding its role in patients undergoing percutaneous coronary intervention (PCI) is scarce. We evaluated consecutive patients undergoing PCI with drug eluting stents from 2012 to 2017, excluding those with unavailable baseline HDL, age

Keywords:

High-density lipoprotein
Internal medicine
in patient
Drug
Cardiology
Lipoprotein
Percutaneous coronary intervention
Conventional PCI
Medicine
cardiovascular outcomes

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations